Is Demerol an Opioid? Uses, Risks, and Interactions

Yes, Demerol is an opioid. Its generic name is meperidine (also called pethidine outside the United States), and it is classified as a synthetic opioid in the phenylpiperidine class. The U.S. Drug Enforcement Administration lists it as a Schedule II controlled substance, placing it in the same category as oxycodone, fentanyl, and hydromorphone.

How Demerol Works

Demerol activates the same pain-blocking receptors in the brain that morphine does, known as mu-opioid receptors. What makes it unusual is that the drug itself binds to those receptors relatively weakly compared to other opioids, yet it still produces strong pain relief. That’s because meperidine crosses from the bloodstream into the brain very efficiently, compensating for its lower binding strength.

In terms of raw potency, Demerol is significantly weaker than morphine milligram for milligram. It takes roughly 75 mg of injected Demerol to match the pain relief of 10 mg of injected morphine. Taken by mouth, the gap widens even further: about 300 mg of oral Demerol equals 30 mg of oral morphine.

What Demerol Is Used For

Demerol was originally developed to treat moderate to severe pain and was once a go-to choice in hospitals, especially after surgery. It also has a well-known role in treating post-anesthesia shivering, an involuntary shaking that sometimes occurs after general anesthesia. For that specific use, it works through a mechanism that other opioids don’t replicate as effectively.

Despite still being available, Demerol’s role in modern medicine has shrunk considerably. Many hospitals have actively worked to phase it out in favor of alternatives like morphine. One pharmacist-led initiative at a surgical hospital reduced the rate of Demerol prescriptions from 49% of surgical patients to about 34% in a single year, and efforts to eliminate its use entirely continue across healthcare systems. The shift happened because the risks of Demerol, particularly with repeated dosing, are now considered to outweigh its benefits for most patients.

Why Demerol Carries Extra Risks

The biggest concern with Demerol is what happens when your body breaks it down. Your liver converts meperidine into a byproduct called normeperidine, which lingers in the body much longer than the drug itself. While the pain-relieving effects of Demerol wear off in a few hours, normeperidine can stick around for 15 to 20 hours or longer. As it accumulates with repeated doses, normeperidine can overstimulate the nervous system, causing anxiety, muscle twitching, tremors, and in serious cases, seizures.

This problem is especially dangerous for anyone with reduced kidney function, because the kidneys are responsible for clearing normeperidine from the body. When the kidneys can’t keep up, the toxic byproduct builds to harmful levels much faster. Older adults, who naturally have declining kidney function, are at particularly high risk.

Dangerous Drug Interactions

Demerol has a potentially fatal interaction that sets it apart from most other opioids. When combined with a class of antidepressants called MAO inhibitors, or taken within 14 days of stopping one, the combination can cause severe respiratory depression, dangerously low blood pressure, coma, and a condition called serotonin syndrome. The FDA label lists this as an absolute contraindication, meaning the two should never be combined under any circumstances.

Serotonin syndrome is also a risk when Demerol is taken alongside more commonly prescribed antidepressants like SSRIs (the class that includes fluoxetine and sertraline). Symptoms include agitation, rapid heart rate, high body temperature, and muscle rigidity. Because so many people take SSRIs, this interaction is one more reason clinicians have moved away from prescribing Demerol when safer opioid alternatives exist.

Addiction and Dependence

Like all Schedule II opioids, Demerol carries a high potential for abuse and physical dependence. With regular use, your body adapts to the drug, requiring higher doses for the same effect (tolerance) and producing withdrawal symptoms if you stop abruptly. The withdrawal profile is similar to other opioids: nausea, sweating, muscle aches, anxiety, and insomnia.

Demerol also produces euphoria, which contributes to its misuse potential. Its relatively short duration of action, typically two to four hours, means people in pain may take it more frequently, which accelerates both tolerance and the dangerous buildup of normeperidine. This combination of short-lived relief and long-lasting toxic byproducts is a core reason the medical community has largely moved on to other options for pain management.